Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

10372	Companies
216173	Keywords
145882	Articles
114461	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 04/20/2026 at 22:15, 19 days 11 hours ago

Jaguar Health Reports Approval of All Proposals at April 2026 Special Meeting of Stockholders
Jaguar Health, Inc. announces voting results of Special Meeting of Stockholders with five approved proposals for novel prescription drugs derived from plants for GI and mental health indications

Forward-looking Statements Special Meeting Jaguar Health Stockholders Prescription Drugs
BRIEF

published on 04/13/2026 at 14:35, 26 days 19 hours ago

Jaguar Health explore l'IA dans le développement du crofélémer pour l'insuffisance intestinale

Jaguar Health L'IA Dans Le Secteur De La Santé Développement Crofelemer Traitement MVID Insuffisance Intestinale
BRIEF

published on 04/13/2026 at 14:35, 26 days 19 hours ago

Jaguar Health Explores AI in Crofelemer Development for Intestinal Failure

Jaguar Health AI In Healthcare Crofelemer Development MVID Treatment Intestinal Failure
PRESS RELEASE

published on 04/13/2026 at 14:30, 26 days 19 hours ago

Artificial Intelligence (AI) Platforms Could Enhance Jaguar Health's Development and Anticipated Commercialization of Crofelemer for Rare Disease Intestinal Failure (IF) Programs
Jaguar Health plans to utilize AI platforms to enhance the development and commercialization of crofelemer for intestinal failure treatment, targeting ultrarare pediatric disorder MVID

Crofelemer Jaguar Health MVID AI Platforms Intestinal Failure
BRIEF

published on 04/10/2026 at 02:20, 1 month ago

Jaguar Health Schedules Investor Webcast on Q4 2025 Financials

Financial Updates Forward-looking Statements Investor Webcast Jaguar Health Gastrointestinal Treatments
BRIEF

published on 04/10/2026 at 02:20, 1 month ago

Jaguar Health programme une webdiffusion pour les investisseurs sur ses résultats financiers du quatrième trimestre 2025.

Jaguar Health Déclarations Prospectives Actualités Financières Webinaire Pour Les Investisseurs Traitements Gastro-intestinaux
PRESS RELEASE

published on 04/10/2026 at 02:15, 1 month ago

Reminder: Jaguar Health to Host Investor Webcast at 8:30 am Eastern on Friday, April 10, 2026 Regarding Q4 2025 Financials and Company Updates
Jaguar Health, Inc. announces participation details for upcoming webcast on April 10, 2026. Learn about their novel prescription drugs derived from plants for GI diseases

Forward-looking Statements Webcast Jaguar Health GI Diseases Prescription Drugs
BRIEF

published on 04/08/2026 at 14:35, 1 month 1 day ago

Jaguar Health achève l'essai du Crofelemer pour le CID chez les chiens

Crofelemer Jaguar Health Approbation De La FDA Chimiothérapie Canine Traitement De La Diarrhée
BRIEF

published on 04/08/2026 at 14:35, 1 month 1 day ago

Jaguar Health Completes Crofelemer Trial for CID in Dogs

Crofelemer FDA Approval Jaguar Health Dog Chemotherapy Diarrhea Treatment
PRESS RELEASE

published on 04/08/2026 at 14:30, 1 month 1 day ago

Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Jaguar Health, Inc. completes study on crofelemer for cancer therapy-induced diarrhea in dogs. Results expected to complement positive outcomes. Company plans to file effectiveness study by Q2 2026

Crofelemer Jaguar Health Cancer Therapy Diarrhea Dogs

Accesswire

Published on 05/09/2026 at 01:55, 1 day 8 hours ago

Prospect Ridge Announces Board Resignation
Published on 05/09/2026 at 01:40, 1 day 8 hours ago

Findev Inc. Issues Corrective Disclosure
Published on 05/09/2026 at 01:30, 1 day 8 hours ago

Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 1 day 10 hours ago

Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 23:01, 1 day 11 hours ago

Water Ways Announces Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 05/09/2026 at 19:05, 15 hours ago

LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 1 day 13 hours ago

EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 1 day 14 hours ago

EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 1 day 15 hours ago

Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/08/2026 at 18:29, 1 day 15 hours ago

Designated Person Notification

Les Echos

Published on 05/07/2026 at 19:15, 2 days 14 hours ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 2 days 14 hours ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 2 days 14 hours ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 2 days 14 hours ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 2 days 15 hours ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE